Skip to main content
Premium Trial:

Request an Annual Quote

Ambion Licenses siRNA Patent Application from City of Hope Medical Center

NEW YORK, July 22 - Ambion, of Austin, Texas, has exclusively licensed short interfering RNA technology described in a patent application from the City of Hope National Medical Center and Beckman Research Institute, the company said today.


The application stems from an invention by John  Rossi, chair of the division of Molecular Biology at City of Hope Comprehensive Cancer Center. It covers technologies for expressing siRNA from PCR products, the company said. This technology is designed for quick preparation of siRNA expression cassettes without cloning or sequencing.


The company, which sells a variety of siRNA-related products to the research market, did not disclose the financial terms of the licensing deal.



The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.